Stimulation of peroxisome
proliferator-activated receptors (PPARs) causes mesenchymal stem cells of the
human bone marrow differentiate into adipocytes instead of osteoblasts leading
to a decreased number of osteoblasts and a decrease in bone mineral density
(BMD). Thus, PPARs may have impacts on bone metabolism. 224 postmenopausal
women (171 osteoporotic and osteopenic, 53 healthy control) were included in
this study. Polymerase chain reaction-restriction fragment length polymorphism
(PCR-RFLP) and agarose gel electrophoresis techniques were performed to detect
PPARα L162V and PPARγ Pro12Ala/C161T polymorphisms. The distribution of PPARγ
Pro12Ala genotype and allele frequencies was not statistically different in
control and patient (osteopenic+osteoporotic) groups (p>0.05). However, in
the patient group, subjects with “Pro12Pro” genotype had lower lumbar spine
(L1-L4) BMD values than those with “Ala” allele (p<0.05). The frequency of
PPARγ C161T “CC” genotype was higher in the patient group when compared with
that in the control group (p<0.05). There were no significant associations
between the genotype and allele frequencies of PPARγ C161T/ PPARα L162V and BMD
values (p>0.05). We suggested that PPARγ Pro12Ala and C161T gene variants
might be contributing factors in the development of osteoporosis.
Peroxisome proliferator-activated receptor bone mineral density osteoporosis polymorphism
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Original Article |
Yazarlar | |
Yayımlanma Tarihi | 2 Mayıs 2019 |
Gönderilme Tarihi | 17 Mart 2019 |
Yayımlandığı Sayı | Yıl 2019 Cilt: 49 Sayı: 1 |